|

EB-G3B7-NK dual-target CAR-NK cells Clinical Trials

1 actively recruiting trial

Also known as: Dual-target GPC3/B7-H3 CAR-NK; G3B7-NK; EB-G3B7-NK

Pipeline

Phase 1/2: 1

Top Sponsors

  • Beijing Biotech1

Indications

  • Liver Disease1
  • Advanced Hepatocellular Carcinoma (HCC)1
  • Metastatic Liver Cancer1
  • Liver Cancer1
  • Cancer1

Other1 trial

Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.